Differential Fuel Requirements of Human NK Cells and Human CD8 T Cells: Glutamine Regulates Glucose Uptake in Strongly Activated CD8 T Cells.
Adult
CD28 Antigens
/ immunology
CD3 Complex
/ immunology
CD56 Antigen
/ metabolism
CD8-Positive T-Lymphocytes
/ cytology
Female
Glucose
/ metabolism
Glutamine
/ metabolism
Humans
Immunity, Cellular
Interferon-gamma
/ biosynthesis
Interleukin-12
/ metabolism
Interleukin-18
/ metabolism
Killer Cells, Natural
/ immunology
Male
Journal
ImmunoHorizons
ISSN: 2573-7732
Titre abrégé: Immunohorizons
Pays: United States
ID NLM: 101708159
Informations de publication
Date de publication:
08 05 2020
08 05 2020
Historique:
received:
03
04
2020
accepted:
13
04
2020
entrez:
10
5
2020
pubmed:
10
5
2020
medline:
3
8
2021
Statut:
epublish
Résumé
CD8 T cells and NK cells are the two major cytotoxic lymphocytes that carry out cell-mediated immunity and regulate other immune responses. However, we do not completely understand human CD8 T cell and NK cell metabolic requirements and they have not been compared in the same experiments. We activated human CD8 T cells by two anti-CD3/CD28 mAb methods, and we stimulated both CD8 T cells and NK cells with IL-12/IL-18. When glucose (Glc) could not be used, human CD8 T cells either died or became hypofunctional, depending upon the anti-CD3/CD28 activation method. In contrast, Glc starvation did not decrease the percentage of IL-12/IL-18-stimulated human NK cells that made IFN-γ. NK cells were relatively fuel resilient and used Glc, glutamine (Gln), fatty acid, or acetate to power IFN-γ expression. Surprisingly, strongly activated human CD8 T cells required Gln for glycolysis and Glc uptake. We showed that human CD8 T cells regulate Glc uptake by a novel mechanism related to the TXNIP pleiotropic protein. These conditions may be relevant to septic patients who have high blood Glc but low Gln. Under the conditions tested, Gln did not change human NK cell TXNIP expression. Our experiments reveal fundamental differences in human CD8 T cell and NK cell metabolism and the fuels needed for IFN-γ production.
Identifiants
pubmed: 32385048
pii: 4/5/231
doi: 10.4049/immunohorizons.2000020
pmc: PMC9582898
mid: NIHMS1830260
doi:
Substances chimiques
CD28 Antigens
0
CD3 Complex
0
CD56 Antigen
0
Interleukin-18
0
Glutamine
0RH81L854J
Interleukin-12
187348-17-0
Interferon-gamma
82115-62-6
Glucose
IY9XDZ35W2
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
231-244Subventions
Organisme : NCI NIH HHS
ID : P30 CA177558
Pays : United States
Organisme : NCI NIH HHS
ID : R25 CA221765
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000117
Pays : United States
Commentaires et corrections
Type : ErratumIn
Informations de copyright
Copyright © 2020 The Authors.
Références
Eur J Biochem. 1993 Feb 15;212(1):95-9
pubmed: 8444168
J Autoimmun. 2012 Sep;39(3):206-15
pubmed: 22704425
Nat Immunol. 2014 Aug;15(8):749-757
pubmed: 24973821
Mol Cancer Ther. 2007 Nov;6(11):3049-58
pubmed: 18025288
Immunity. 2014 Dec 18;41(6):886-97
pubmed: 25526304
Proc Natl Acad Sci U S A. 2009 Sep 1;106(35):14878-83
pubmed: 19706488
Cell Metab. 2018 Sep 4;28(3):504-515.e7
pubmed: 30043753
Annu Rev Immunol. 2000;18:275-308
pubmed: 10837060
Immunity. 2011 Dec 23;35(6):871-82
pubmed: 22195744
Immunity. 2005 Feb;22(2):195-208
pubmed: 15723808
Immunity. 2011 Aug 26;35(2):161-8
pubmed: 21867926
Science. 2015 Nov 20;350(6263):985-90
pubmed: 26494174
J Immunol. 2016 Mar 15;196(6):2552-60
pubmed: 26873994
Nature. 2011 Nov 20;481(7381):394-8
pubmed: 22101430
Am J Physiol Endocrinol Metab. 2013 Jun 15;304(12):E1359-64
pubmed: 23612995
Sci Rep. 2018 Apr 19;8(1):6289
pubmed: 29674640
J Cell Biochem. 1993 Dec;53(4):343-51
pubmed: 7905486
J Immunol. 2016 Mar 15;196(6):2541-51
pubmed: 26843329
Science. 2016 Oct 28;354(6311):481-484
pubmed: 27708054
Cell. 2018 Oct 4;175(2):502-513.e13
pubmed: 30245009
Nat Immunol. 2016 Jun;17(6):712-20
pubmed: 27111141
J Thorac Dis. 2016 Jul;8(7):E621-4
pubmed: 27501420
J Nutr. 2001 Sep;131(9 Suppl):2535S-8S; discussion 2550S-1S
pubmed: 11533308
J Immunol. 2013 Mar 1;190(5):2381-90
pubmed: 23345327
Crit Care. 2013 Mar 06;17(2):305
pubmed: 23470218
Neurol Neuroimmunol Neuroinflamm. 2017 Dec 22;5(1):e425
pubmed: 29296633
Nat Cell Biol. 2016 Oct;18(10):1090-101
pubmed: 27617932
PLoS Med. 2007 May;4(5):e158
pubmed: 17472435
J Thorac Oncol. 2011 Mar;6(3):432-8
pubmed: 21258248
Cancer. 1997 Jun 15;79(12):2320-8
pubmed: 9191519
Cell Cycle. 2012 Nov 1;11(21):3919-25
pubmed: 22983094
Cancer J. 2014 Mar-Apr;20(2):151-5
pubmed: 24667962
Annu Rev Nutr. 1986;6:211-24
pubmed: 3524617
Cold Spring Harb Perspect Med. 2013 Sep 01;3(9):a014258
pubmed: 24003245
Cell. 2015 Sep 10;162(6):1217-28
pubmed: 26321681
J Immunol. 2015 Oct 15;195(8):4010-9
pubmed: 26363055
J Immunol. 2015 Feb 15;194(4):1954-62
pubmed: 25595780
Eur J Immunol. 2015 Sep;45(9):2504-16
pubmed: 26114249
Adv Immunol. 1989;47:187-376
pubmed: 2683611
Cell Stem Cell. 2007 Sep 13;1(3):313-23
pubmed: 18371365
Science. 2015 Jan 9;347(6218):194-8
pubmed: 25567907
Immunity. 2014 May 15;40(5):692-705
pubmed: 24792914
Cell Rep. 2018 Apr 17;23(3):741-755
pubmed: 29669281
Cell. 2013 Jun 6;153(6):1239-51
pubmed: 23746840
Nat Commun. 2018 Jun 14;9(1):2341
pubmed: 29904050
J Immunol. 2005 Apr 15;174(8):4670-7
pubmed: 15814691
Ann Oncol. 2017 Dec 1;28(suppl_12):xii18-xii32
pubmed: 29045511
Cell Metab. 2014 Jul 1;20(1):61-72
pubmed: 24930970
Cancer Res. 2013 Jun 15;73(12):3499-510
pubmed: 23592754
Immunity. 2015 Jan 20;42(1):41-54
pubmed: 25607458
PLoS One. 2014 Aug 04;9(8):e104104
pubmed: 25090630
Cancer Immunol Res. 2018 Jan;6(1):14-24
pubmed: 29097422
Nat Immunol. 2013 Oct;14(10):1064-72
pubmed: 23955661
Cancer Res. 1964 Jun;24:780-94
pubmed: 14190544
Blood. 2005 Apr 15;105(8):3051-7
pubmed: 15632206
Proc Natl Acad Sci U S A. 2016 Mar 1;113(9):2460-5
pubmed: 26869716
J Clin Invest. 2018 Apr 2;128(4):1384-1396
pubmed: 29324443
Nat Rev Cancer. 2016 Jan;16(1):7-19
pubmed: 26694935
BMC Med. 2016 Oct 21;14(1):163
pubmed: 27769244
J Immunol. 2010 Jul 15;185(2):1037-44
pubmed: 20554958
Cancer Res. 2015 Feb 1;75(3):544-53
pubmed: 25644265
J Immunol. 2014 Nov 1;193(9):4477-84
pubmed: 25261477